XML 16 R6.htm IDEA: XBRL DOCUMENT v3.19.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Common Stock [Member]
Additional Paid In Capital [Member]
Accumulated Other Comprehensive Loss [Member]
Accumulated Deficit [Member]
Total Ionis Stockholders' Equity [Member]
Noncontrolling Interest in Akcea Therapeutics, Inc. [Member]
Total
Balance at Dec. 31, 2017 $ 125 $ 1,553,681 $ (31,759) $ (1,241,034) $ 281,013 $ 84,267 $ 365,280
Balance (in shares) at Dec. 31, 2017 124,976            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) $ 0 0 0 (1,420) (1,420) 0 (1,420)
Change in unrealized gains (losses), net of tax 0 0 (1,530) 0 (1,530) 0 (1,530)
Foreign currency translation 0 0 55 0 55 0 55
Issuance of common stock in connection with employee stock plans $ 0 5,664 0 0 5,664 0 5,664
Issuance of common stock in connection with employee stock plans (in shares) 473            
Stock-based compensation expense $ 0 28,451 0 0 28,451 0 28,451
Noncontrolling interest in Akcea Therapetuics, Inc. 0 (10,842) 0 0 (10,842) 1,443 (9,399)
Balance at Mar. 31, 2018 $ 125 1,576,954 (33,234) (1,242,454) 301,391 85,710 387,101
Balance (in shares) at Mar. 31, 2018 125,449            
Balance at Dec. 31, 2018 $ 138 2,047,250 (32,016) (967,293) 1,048,079 139,081 1,187,160
Balance (in shares) at Dec. 31, 2018 137,929            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) $ 0 0 0 84,443 84,443 0 84,443
Change in unrealized gains (losses), net of tax 0 0 4,324 0 4,324 0 4,324
Foreign currency translation 0 0 84 0 84 0 84
Issuance of common stock in connection with employee stock plans $ 2 67,057 0 0 67,059 0 67,059
Issuance of common stock in connection with employee stock plans (in shares) 1,825            
Stock-based compensation expense $ 0 45,505 0 0 45,505 0 45,505
Payments of tax withholdings related to vesting of share-based awards $ 0 (7,597) 0 0 (7,597) 0 (7,597)
Payments of tax withholdings related to vesting of share-based awards (in shares) (130)            
Noncontrolling interest in Akcea Therapetuics, Inc. $ 0 (34,246) 0 0 (34,246) 40,688 6,442
Balance at Mar. 31, 2019 $ 140 $ 2,117,969 $ (27,608) $ (882,850) $ 1,207,651 $ 179,769 $ 1,387,420
Balance (in shares) at Mar. 31, 2019 139,624